Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 28 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Hyperglycemia potentiates the slowing of gastric emptying induced by exogenous GLP-1Plummer, M.; Jones, K.; Cousins, C.; Trahair, L.; Meier, J.; Chapman, M.; Horowitz, M.; Deane, A.
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2013Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetesWu, T.; Bound, M.; Zhao, R.; Standfield, S.; Bellon, M.; Jones, K.; Horowitz, M.; Rayner, C.
2015Sustained effects of a protein 'preload' on glycaemia and gastric emptying over 4 weeks in patients with type 2 diabetes: A randomized clinical trialMa, J.; Jesudason, D.R.; Stevens, J.E.; Keogh, J.B.; Jones, K.L.; Clifton, P.M.; Horowitz, M.; Rayner, C.K.
2013Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetesChang, J.; Wu, T.; Greenfield, J.; Samocha-Bonet, D.; Horowitz, M.; Rayner, C.
2013Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetesYoung, R.; Chia, C.; Isaacs, N.; Ma, J.; Khoo, J.; Wu, T.; Horowitz, M.; Rayner, C.
2013Mechanisms and clinical efficacy of lixisenatide for the management of type 2 DiabetesHorowitz, M.; Rayner, C.; Jones, K.
2013Prognosis of diabetic gastroparesisa 25-year evaluationChang, J.; Rayner, C.; Jones, K.; Horowitz, M.
2016Small intestinal glucose delivery affects the lowering of blood glucose by acute vildagliptin in type 2 diabetesWu, T.; Zhang, X.; Trahair, L.; Bound, M.; Little, T.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2011Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetesDeane, A.; Summers, M.; Zaknic, A.; Chapman, M.; Fraser, R.; Di Bartolomeo, A.; Wishart, J.; Horowitz, M.